Non-invasive tests in animal models and humans: A new paradigm for assessing efficacy of biologics including prebiotics and probiotics

Current Pharmaceutical Design

Volumn 14, Issue 14, 2008, Pages 1341-1350

  Butler, Ross N ^a  

^a North Adelaide SA   (United States)

Author keywords

Breath tests; Gut function; Non invasive tests; Probiotics

Indexed keywords

ALCOHOL; BIOLOGICAL PRODUCT; CLARITHROMYCIN; FLUOROURACIL; METHOTREXATE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PANCREAS ENZYME; PREBIOTIC AGENT; PROBIOTIC AGENT; VIRUS VACCINE;

ANTIBIOTIC RESISTANCE; BIOLOGICAL THERAPY; BREATH ANALYSIS; CANCER PATIENT; COLON DISEASE; COMMERCIAL PHENOMENA; CYSTIC FIBROSIS; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; ENTERITIS; ENTEROPATHY; ENZYME REPLACEMENT; GASTROINTESTINAL TOXICITY; GLUTEN FREE DIET; HELICOBACTER INFECTION; HUMAN; INTESTINE MUCOSA PERMEABILITY; METABOLIC ACTIVATION; MUCOSA INFLAMMATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; ORAL REHYDRATION THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE DISEASE; STOMACH ABSORPTION; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH MOTILITY; STOMACH PROTECTION; SUCROSE BREATH TEST; UREA BREATH TEST;

ANIMALS; BIOLOGICAL PRODUCTS; BREATH TESTS; CYSTIC FIBROSIS; DIARRHEA; GASTRIC EMPTYING; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HUMANS; INTESTINAL MUCOSA; MICE; MODELS, ANIMAL; PROBIOTICS; RATS;

EID: 47249126278     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784480180     Document Type: Review

References (72)

1. Mattick JS. The human genome and the future of medicine. Med J Aust 2003; 179(4): 212-6.
2. Butler RN. Biochemical tests of small intestinal function. In: Ratnaike RN Ed. Small bowel disorders 2000; 222-30.
3. Schneeman BO. Gastrointestinal physiology and functions. Nutr Cancer 2005; 51(1): 102-9.
4. Zoon KC. Future directions in cancer research: Impact of the completion of the human genome Toxicol Pathol 2004; 32(Suppl 1): 1-2.
5. Mager J, Bartolomei MS. Strategies for dissecting epigenetic mechanism in the mouse. Nat Genet 2005; 37(11): 1194-200.
6. Bengmark S, Martindale R. Prebiotics and synbiotics in clinical medicine. Nutr Clin Pract 2005; 20(2): 244-61.
7. Chen CC, Walker WA Probiotics and prebiotics: Role in clinical disease states. Adv Pediatr 2005; 52: 77-113.
8. 2 breath tests for investigating gastrointestinal functions. Food Nutr Bull 2002; 23(3 Suppl): 166-8.
9. Davidson GP, Butler RN. Breath tests In: Walker A, Durie P, Hamilton J Eds, Paediatric gastroenterology. Walker-Smith J 2000: 1529-37.
10. 2 breath tests and stable isotopes for investigating gas rointestinal functions. Acta Gastroenterol Belg 2000; 63(4): 325-7.
11. Kirby RJ, Howles PN, Hui DY. Rate of gastric emptying influences dietary cholesterol absorption efficiency in selected inbred strains of mice. Dig Dis Sci 2004; 49(7-8):1095-102.
12. Chapman M, Fraser R, Vozzo R, Bryant L, Tam W, Nguyen N, et al. Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut 2005; 54(10): 1384-90.
13. Russo A, Stevens JE, Chen R, Gentilcore D, Burnet R, Horowitz M, et al. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005; 90(8):4489-95.
14. Taylor CJ, Hillel PG, Ghosal S, Frier M, Senior S, Tindale WB, et al. Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis. Arch Dis Child 1999; 80(2):149-52.
15. Borowitz D, Durie PR, Clarke LL, Werlin SL, Taylor CJ, Semler J, et al. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 2005; 41(3): 273-85.
16. Leontiadis GI, Minopoulos GI, Maltezos E, Kotsiou S, Manolas KI, Simopoulos K, et al. Effects of Helicobacter pylori infection on gastric emptying rate in patients with non-ulcer dyspepsia. World J Gastroenterol 2004; 10(12): 1750-4.
17. Chang FY, Lu CL, Chen CY, Luo JC, Jium KL, Lee SD. Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer. J Gastroenterol Hepatol 2003; 18(11): 1250-6.
18. EL Symonds, H Huynh, TI Omari, GP Davidson, RN Butler. Gastritis in the mouse causes delay and dysmotility in gastric emptying. J Gastroenterol Hepatol 2001; 16(Suppl): A96.
19. Galligan JJ, Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005; 17(5): 643-53.
20. 13C-octanoic acid breath test. Clin Exp Pharmacol Physiol 2000; 27: 671-5.
21. Symonds E, Butler RN, Omari T. Non-invasive tests can detect alterations in Gastric Emptying in the Mouse. Eur J Clin Invest 2002; 32: 341-4.
22. Hughes RJ, Symonds EL, Tivey DR, Butler RN. Breath tests for evaluating gastro-intestinal function in broiler chickens. Proc Aust Poult Sci Sym 2000; 12: 170-3.
23. Tivey DR, Butler RN. Recent advances in animal nutrition. In: Corbett JL Ed. University of New England 1999; 45-52.
24. Sutton DG, Bahr A, Preston T, Christley RM, Love S, Roussel AJ. Validation of the 13C-octanoic acid breath test for measurement of equine gastric emptying rate of solids using radioscintigraphy. Equine Vet J 2003; 35(1): 27-33.
25. Page AJ, Brierley SM, Martin CM, Wemmie JA, Price MP, Symonds E, et al. Different contributions of ASIC channels 1,2 and 3 to visceral mechanoreceptor function. Gut 2005; 54(10): 1408-15.
26. Symonds E, Omari TI, Butler RN. Gastric emptying rate is influenced by the excretion of colonic gas. Gastroenterology 2003; 124 (4, Suppl 1): A678.
27. McLoughlin R, O'Morain C. Effectiveness of antiinfectives Chemotherapy 2005; 51(5): 243-6.
28. Bytzer P, O'Morain C. Treatment of Helicobacter pylori. Helicobacter. 2005; 10(Suppl 1):40-6.
29. Lee SK, Josenhans C. Helicobacter pylori and the innate immune system. Int J Med Microbiol 2005; 295(5): 325-34.
30. Kamiji MM, de Oliveira RB. Non-antibiotic therapies for helicobacter pylori infection. Eur J Gastroenterol Hepatol 2005; 17(9): 973-81.
31. Datta S, Chattopadhyay S, Patra R, De R, Ramamurthy T, Hembram J, et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other (drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther 2005; 22(1): 51-7.
32. Hammond P, Stutzenberger F, Butler RN, Read LC. Use of a disposable syringe as a novel, economical breath collection chamber for mice. Contemporary Topics Lab Animal Sci 1998; 37(3):70-1.
33. Crone J, Symonds E, Campbell F, Butler R. Evaluation of a monoclonal stool antigen test for detection of Helicobacter pylori in mice. Clin Diag Lab Immun 2004; 11: 799-800.
34. 13C UBT: Reproducibility and association with severity of gastritis. J Hepatol Gastoenterol 2005; 20: 270-4.
35. Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, et al. The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest 1998; 58(1): 19-27.
36. B agonist baclofen on liquid and solid gastric emptying in mice. Eur J Pharmacol 2003; 470: 95-7.
37. FDA. April 2004 Draft - Guidance for industry, exocrine pancreatic insufficiency drug products - submitting NDAs. www.fda.gov/cder/ guidance/index.
38. Symonds EL, Omari TI, Webster JM, Davidson GP, Butler RN. The relation between pancreatic lipase activity and gastric emptying rate in children with cystic fibrosis. J Pediatr 2003; 143: 772-5.
39. Slater C, Preston T, Weaver LT. Is there an advantage in normalising the results of the Helicobacter pylori [13C]urea breath test for CO2 production rate in children? Isotopes Environ Health Stud 2004; 40(1): 89-98.
40. Amarri S, Coward WA, Harding M, Weaver LT. Importance of measuring CO2-production rate when using 13C-breath tests to measure fat digestion. Br J Nutr 1998; 79(6): 541-5.
41. De Boeck K, Delbeke I, Eggermont E, Veereman-Wauters G, Ghoos Y. Lipid digestion in cystic fibrosis: Comparison of conventional and high-lipase enzyme therapy using the mixed-triglyceride breath test. J Pediatr Gastroenterol Nutr 1998; 26(4): 408-11.
42. Slater C, Preston T, Weaver LT. Comparison of accuracy and precision of heart rate calibration methods to estimate total carbon dioxide production during 13C-breath tests or responses to gastric and duodenal nutrient in critically ill patients. Gut 2005; 54(10): 1384-90.
43. Dominguez-Munoz JE, Iglesias-Garcia J, Iglesias-Rey M, Figueiras A, Vilarino-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: A randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21(8): 993-1000.
44. Bryant LK, Fraser RJ, Vozzo R, Zacharakis B, Matthews GM, Butler RN. Stimulation of small intestinal burst activity in the post-prandial state differentially affects lipid and glucose absorption in healthy adult human. Am J Physiol Gastrointest Liver Physiol. 2004; 287(5): G1028-34.
45. 13C-octanoic acid breath tes. Crit Care Med 2001; 29(9):1744-9.
46. Chapman M, Fraser R, de Beaux I, Creed S, Finnis M, Butler R, et al. Cefazolin does not accelerate gastric emptying in the critically ill. Intensive Care Med 2003; 29(7): 1169-72.
47. Chapman M, Fraser R, Vozzo R, Butler R, Davidson G, Horowitz M. Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut 2005; 54(10): 1384-90.
48. Pelton NS, Tivey DR, Howarth GS, Davidson GP, Butler RN. A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol 2004; 39(19): 1015-6.
49. Clarke JM, Pelton N, Bajka BH Howarth GS, Read LC, Butler R. Use of the 13C sucrose breath test to assess chemotherapy-induced small intestinal mucositis in the rat. Cancer Biol Ther 2006; 5(1): 34-8.
50. Inglis K, Saxon B, Webster J, Zacharakis B, Davidson G, Butler R. Non-invasive assessment of chemotherapy-induced intestinal mucositis in children. Support Care Cancer 2005; 13(6): 101: 445.
51. Inglis K, Penning K, Howarth G, Butler R. Oral ingestion of Streptococcus Thermophilus partially attenuates small intestinal mucositis in methotrexate-treated rats. Support Care Cancer 2005; 13(6): Abstract 102:445.
52. Keatley D. Honours thesis, University of Adelaide. 2001.
53. Pike MG, Heddle RJ, Boulton P, Turner MW, Atherton DJ. Increased intestinal permeability in atopic eczema. J Invest Dermatol 1986; 86(2):101-4.
54. 4 differences between Aboriginal Caucasian infants. J Hepatol Gastroenterol 2002; 17: A176.
55. 2 breath test can be used to assess starch digestion and fermentation in humans. J Nutr 2004; 134: 1193-6.
56. Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Gut. 2005; 54(8):1078-84.
57. McGarr SE, Ridlon JM, Hylemon, PB. Diet, anaerobic bacterial metabolism, and colon cancer: A review of the literature. Dig Dis Sci 1987; 32(3): 267-71.
58. Roediger WE. The colonic epithelium in ulcerative colitis: An energy-deficiency disease? Lancet 1980; 2(8197): 712-5.
59. Kavanaugh MJ, Clark C, Goto M, Kovacs EJ, Gamelli RL, Sayeed MM, et al. Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function. Burns 2005; 31(3): 290-6.
60. Kim JW, Jeon WK, Yun JW, Park DI, Cho M Sung IK et al. Protective effects of bovine colostrum on non-steroidal anti-inflammatory drug induced intestinal damage in rats. Asia Pac J Clin Nutr 2005; 14(1): 103-7.
61. Zhang Y, Lee B, Thompson M, Glass R, Cama, RI, Figueroa D, et al. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. Diarrhea Working Group, Peru. J Pediatr Gastroenterol Nutr 2000; 31(1): 16-21.
62. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307(5717): 1920-5.
63. Butler R, Pelton N, Zacharakis B, Tran C, Tivey D, Davidson GP. 13C sucrose breath test - A novel non-invasive test for sucrase activity. J Hepatol. Gastroenterol 2002; 17: A114.
64. Ramakrishna BS, Venkataraman S, Srinivasan P, Dash P, Young GP, Binder HJ. Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med 2000; 342(5): 308-13.
65. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics, 1991; 88(1):90-7.
66. Isolauri E, Kaila M. Arvola T. Majamaa, H, Rantala I, Virtanen E, et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 1993; 33(6): 548-53.
67. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000; 95(1 Suppl): S2-4.
68. Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, et al. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. Eur Rev Med Pharmacol Sci 2005; 9(5):273-17.
69. Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, et al. The treatment of NAFLD. Eur Rev Med Pharmacol Sci 2005; 9(5): 299-304.
70. O'Sullivan GC, Kelly P, O'Halloran S, Collins C, Collins JK, Dunne C, et al. Probiotics: An emerging therapy. Curr Pharm Des 2005; 11(1): 3-10.
71. Quintana E, Barrachina MD, Esplugues JV. Nitrergic modulation of gastrointestinal function during early endotoxemia. Curr Pharm Des 2006; 12(34): 4525-35.
72. Tuohy KM, Rouzaud GC, Bruck WM, Gibson GR. Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Curr Pharm Des 2005; 11(1): 75-90.